JAMA Intern Med July 2017 PMID 28531241

Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.

Benjamin H Han, David Sutin, Jeff D Williamson, Barry R Davis, Linda B Piller, Hannah Pervin, Sara L Pressel, Caroline S Blaum

Full text PDF Download social card

Mentions

121

Peak: 2 in Mar 2019

across 6 sources since May 2017

Extended reach

11,118

potential audience

Total likes

Video views

1,592

Mentions per month

May 2017 – Dec 2024

Where it's discussed

Facebook70 posts
News41 articles
Blogs4 articles
X / Twitter3 posts
YouTube2 videos
Bluesky1 posts

AI synopsis

What people are saying

The discussions mostly highlight key results, such as the lack of benefit from pravastatin in preventing cardiovascular events, with phrases like 'no benefit' and 'not significantly decreasing mortality' demonstrating a critical tone. The tone is generally analytical, referencing the study's implications, but without overt excitement or emotional engagement, reflecting a neutral yet meaningful reception.

AgreementModerate agreement

Most discussions reflect agreement that the study indicates limited benefits of statins for primary prevention in older adults, with several explicitly noting no significant reduction in mortality or cardiovascular events.

InterestNeutral interest

The overall interest appears neutral; discussions mention the study’s findings, but there’s little display of enthusiasm or personal engagement beyond acknowledgment.

EngagementModerate engagement

Some posts engage with the methodology and implications, such as noting that a substantial portion of participants didn’t adhere to medication, suggesting a deeper consideration of the study’s impact.

ImpactModerate impact

The discussions imply the findings could influence clinical practices and guidelines, emphasizing the significance of the study for healthcare decisions in older populations.

Abstract in brief

This study examined whether statin treatment (pravastatin 40 mg) impacts all-cause mortality and cardiovascular events in adults aged 65 and older without existing atherosclerotic cardiovascular disease, by analyzing data from the ALLHATLLT trial.
The results showed that while pravastatin reduced LDL cholesterol levels over six years, it did not significantly decrease overall mortality or prevent nonfatal heart attacks compared to usual care.
A notable finding was that a substantial portion of participants assigned to pravastatin (about 42%) were not taking the medication after six years, which could influence the observed effects of the treatment.]

Read the full abstract

All mentions

Reevaluating LDL-C's Impact on Elderly Mortality and Health Outcomes

Dr. Nasha Winters discusses the lack of a clear relationship between LDL cholesterol levels and mortality in the elderly, highlighting recent findings that suggest higher LDL-C may not be as harmful as once believed…

Janaína Koenen MD · May 26, 2023 993 views

Effectiveness of Statin Therapy in Older Adults for Cardiovascular Prevention

This video reviews JAMA research on statin use for primary cardiovascular prevention in adults aged 65 and older, highlighting that pravastatin did not significantly reduce mortality or prevent heart attacks despite…

VHFILM · May 29, 2017 599 views

Jake Matthews

@jakemat91.bsky.social · Bluesky

Dec 31, 2024 · 1 share View post →

にいやん

@niiyan51 · X

Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial. - PubMed - NCBI https://t.co/U6pHA5xgzp

Dec 31, 2019 · 1,077 followers View post →

ＡＫＴ

@attackontobacco · X

Mar 1, 2019 · 1 share · 513 followers View post →

Dr. bycomet

@bycomet · X

Mar 1, 2019 · 1 like · 1 share · 7,931 followers View post →